ConcertAI has launched an AI-powered platform tailored to payer requirements for reimbursable imaging biomarkers.
TeraRecon DETECT offers access to AI biomarkers for radiology (such as liver and bone density) and cardiology (such as plaque analysis) and integrates healthcare IT systems and advanced visualization to streamline prior authorization and operational processes, according to the firm.
The product also determines patient eligibility and supports longitudinal case management, it added.
